US SMALL/MIDCAPS-Stocks fall as worries over economy rise
NEW YORK, June 10
NEW YORK, June 10 (Reuters) - Small- and mid-capitalization stocks declined on Friday, as unease increased about sluggishness in the economy and the end of the Federal Reserve's stimulus, and more downside was expected.
The Fed's second round of bond buying, or QE2, is scheduled to end this month, and while some analysts see little effect from the event, others say it's a further cause for worry in a market that is struggling to hold recent gains.
Recent U.S. economic data has been mostly weaker than expected, suggesting the recovery from the nation's worst downturn since the 1930s could take longer than expected or the economy could be getting weaker.
"A lot of people expected that by the end of QE2 we would see an economy that is accelerating, and we're seeing the opposite. So you're left with, 'What happens next?' I don't think the Fed will be able to make a convincing case of why QE3 would work this time," said Shawn Hackett, president at Hackett advisors in Boynton Beach, Florida.
"We're in a period where we should be in an extended correction," he said.
Industrials were among leading decliners, including Terex Corp (TEX.N), down 2.9 percent at $25.13.
Also, shares of Corinthian Colleges Inc (COCO.O) fell 6.6 percent to $4.31 after Deutsche Bank cut its price target on the company. Career Education Corp (CECO.O) was down 4.2 percent at $21.22.
The S&P MidCap 400 index .MID was down 0.9 percent while the S&P SmallCap 600 index .SML was down 0.9 percent. In comparison, the benchmark S&P 500 .SPX fell 0.9 percent.
The mid-cap index is down about 7.7 percent since May 2, after which major indexes began to lose ground.
Among decliners were shares of LaBranche & Co LAB.N, down 2.3 percent at $3.78, after Standard & Poor's said it will be replaced by OYO Geospace Corp OYOG.O, up 4.3 percent at $94.98, in the S&P SmallCap 600 index. American Medical Systems Holdings AMMD.O was flat at $29.95 after S&P said it will be replaced by NuVasive Inc (NUVA.O), up 2.4 percent at $33.62.
Endo Pharmaceuticals Holdings Inc (ENDP.O) is acquiring American Medical Systems while Cowen Group Inc (COWN.O) is acquiring LaBranche. Final approvals are still pending. (Editing by Padraic Cassidy)
- Qatar adamant it will host 2022 World Cup despite doubts
- Argentina's Fernandez to meet billionaire investor Soros in New York
- New Jersey hiker killed by black bear : police
- Islamic State urges attacks on U.S., French citizens, taunts Obama
- Housing data hits Wall Street; S&P has worst day since August 5 |